MODERN DIAGNOSTIC METHODS OF TUBERCULOSIS

Authors

  • Abdurahmonova K.R Assistant of the Department of Microbiology, Virology, Immunology, TDTU Author
  • Xasanova S.T Student of the 2nd Faculty of Medicine, TDTU Author
  • Hoshimova Z.Y Student of the 2nd Faculty of Medicine, TDTU Author
  • Norboyeva S.Z Student of the 2nd Faculty of Medicine, TDTU Author

DOI:

https://doi.org/10.5281/zenodo.20187670

Keywords:

Mycobacterium tuberculosis, molecular diagnostics, polymerase chain reaction (PCR), multiplex PCR, nucleic acid amplification tests (NAAT), GeneXpert, LAMP

Abstract

This article reviews modern diagnostic approaches to the study of tuberculosis (TB) infections and their clinical and epidemiological significance. The article analyzes the possibilities of detecting Mycobacterium tuberculosis using molecular-genetic methods, in particular polymerase chain reaction (PCR), multiplex PCR, nucleic acid amplification tests (NAAT), GeneXpert and LAMP technologies, along with traditional bacteriological methods. The sensitivity and specificity of these methods, their diagnostic efficiency based on various clinical samples, and their role in determining drug resistance are also discussed. It is emphasized that molecular diagnostic methods play an important role in early detection of TB, differential diagnosis and selection of treatment strategies. In addition, the article analyzes the global epidemiological situation of TB, the problem of co-infection with HIV, and the negative impact of the disease on life expectancy. These approaches are an important tool in optimizing preventive measures aimed at early detection of TB, increasing treatment effectiveness and reducing the burden of the disease. The results of the article serve to improve modern diagnostic and treatment strategies.

References

1.BoehmeCCNabetaPHenostrozaGRaqibRRahimZGerhardtMetal. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol. (2007) 45:1936–40. 10.1128/JCM.02352-06.

2.Cao Y, Parmar H, Gaur RL, Lieu D, Raghunath S, Via N, et al. Xpert MTB/XDR:a 10-Color reflex assay suitable for point-of-care settings to detect isoniazid, fluoroquinolone, and second-line-injectable-drug resistance directly from Mycobacterium tuberculosis-positive sputum. J Clin Microbiol. 2021;59:e02314–20. doi: 10.1128/JCM.02314-20. [DOI] [PMC free article] [PubMed] [Google Scholar]

3.Centers for Disease Control and Prevention (CDC) Update: Nucleic Acid Amplification Tests for Tuberculosis. MMWR Morb Mortal Wkly Rep. 2000;49:593–594. [ PubMed ] [ Google Scholar ]

4.Centers for Disease Control and Prevention (CDC) Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009;58:7–10. [ PubMed ] [ Google Scholar]

5.Cheng VC, Yew WW, Yuen KY. Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis. 2005;24:711–720. doi: 10.1007/s10096-005-0039-1. [DOI] [PubMed] [Google Scholar]

6.Dong B, He Z, Li Y, Xu X, Wang C, Zeng J. Improving traditional and new approaches in the diagnosis of tuberculosis. Front Microbiol. 2022;13:924410. doi: 10.3389/fmicb.2022.924410. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]

7.Gopinath K, Singh S. Multiplex PCR assay for simultaneous detection and differentiation of Mycobacterium tuberculosis, Mycobacterium avium complexes and other mycobacterial species directly from clinical specimens. J Appl Microbiol. 2009;107:425–35. doi: 10.1111/j.1365-2672.2009.04218.x. [ DOI ] [ PubMed ] [ Google Scholar ].

8.Gopinath K, Singh S. Multiplex PCR assay for simultaneous detection and differentiation of Mycobacterium tuberculosis, Mycobacterium avium complexes and other mycobacterial species directly from clinical specimens. J Appl Microbiol. 2009;107:425–35. doi: 10.1111/j.1365-2672.2009.04218.x. [ DOI ] [ PubMed ] [ Google Scholar ]

9.HolmesK. K.BertozziS.BloomB. R.JhaP. (Eds.) (2017). Major infectious diseases (Washington (DC: The International Bank for Reconstruction and Development / The World Bank© 2017 International Bank for Reconstruction and Development / The World Bank).

10.Janssen S, Murphy M, Upton C, Allwood B, Diacon AH. Tuberculosis: An Update for the Clinician. Respirology. 2025 Mar;30(3):196-205. doi: 10.1111/resp.14887. Epub 2025 Jan 31. PMID: 39887565; PMCID: PMC11872285.

11.KayA. W.González FernándezL.TakwoingiY.EisenhutM.DetjenA. K.SteingartK. R.et al. (2020). Xpert MTB/RIF and xpert MTB/RIF ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst. Rev.8 (8), Cd013359. doi: 10.1002/14651858.CD013359.pub2

12.Lakoh S, Jiba DF, Adekanmbi O, Poveda E, Sahr F, Deen GF, Foray LM, Gashau W, Hoffmann CJ, Salata RA, Yendewa GA. Diagnosis and treatment outcomes of adult tuberculosis in an urban setting with high HIV prevalence in Sierra Leone: A retrospective study. Int J Infect Dis. 2020 Jul;96:112-118. doi: 10.1016/j.ijid.2020.04.038. Epub 2020 Apr 24. PMID: 32339724

13.Lee H, Kim J, Kim J, Park YJ. 2023년 국제 결핵 발생 현황 [Review of the Global Burden of Tuberculosis in 2023: Insights from the WHO Global Tuberculosis Report 2024]. Jugan Geongang Gwa Jilbyeong. 2025 Mar 20;18(11 Suppl):55-69. doi: 10.56786/PHWR.2025.18.11suppl.5. Epub 2025 Mar 5. PMID: 41333077; PMCID: PMC12467144

14.Niemz A, Boyle DS. Point-of-care nucleic acid testing for tuberculosis in high-burden countries. Expert Rev Mol Diagn. 2012;12:687–701. doi: 10.1586/erm.12.71. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar]

15.Ning J, Wang R, Pan Y, Fei X, Jiang W, Martinez L, Zhu L, Qin Z, Liu Q. Impact of tuberculosis on median survival time and years of potential life lost in patients: A scoping review. J Clin Tuberc Other Mycobact Dis. 2025 Oct 16;41:100568. doi: 10.1016/j.jctube.2025.100568. PMID: 41146646; PMCID: PMC12554181

16.Qin L, Zheng R, Fan C, Cai J, Liu Z, Wang J, et al. Identification and evaluation of a novel nucleic acid amplification test target for the accurate detection of Mycobacterium tuberculosis. Clin Chem Lab Med. 2010;48:1501–1505. doi: 10.1515/CCLM.2010.296. [ DOI ] [ PubMed ] [ Google Scholar ]

17.Raviglione M, Sulis G. The WHO End TB Strategy. Lancet Glob Health. 2015;3(10):e571–e572

18.Richard McNerney & Paul Daley. Towards point-of-care testing for active tuberculosis: barriers and opportunities. Nature Reviews Microbiology. 2011;9:204–213.

19.Shankar P, Manjunath N, Mohan KK, Prasad K, Behari M, Sriniwas et al. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet. 1991;337:5–7. doi: 10.1016/0140-6736(91)93328-7. [ DOI ] [ PubMed ] [ Google Scholar ]

20.Sia IG, Wieland ML. Modern concepts in the treatment of tuberculosis. Mayo Clin Proc. 2011;86:348–361. doi: 10.4065/mcp.2010.0820. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]

21.Stewart T. Cole. Learning from the genome sequence of Mycobacterium tuberculosis H37Rv. FEBS Letters. June 4, 1999; 452(1–2): 7–10. [PubMed] [Reference list].

22.Tiwari S, Nataraj G, Kanade S, Mehta P. Diagnosis of pulmonary tuberculosis in children with special emphasis on polymerase chain reaction-based nucleic acid amplification testing. Int J Mycobacteriol. 2015;4:48–53. doi: 10.1016/j.ijmyco.2014.11.063. [ DOI ] [ PubMed ] [ Google Scholar ].

23.WongYPOthmanSLauYLRaduSCheeHY. Loop-mediated isothermal amplification (LAMP): a versatile technique for detection of micro-organisms. J Appl Microbiol. (2018) 124:626–43. 10.1111/jam.13647

24.World Health Organization (2024) Global tuberculosis report 2024. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa.

Downloads

Published

2026-05-14